drugmakers in race for next weight-loss breakthrough – One America News Network

0
227

By Reuters

June 18, 2025 – 7:41 AM PDT

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. REUTERS/Hollie Adams/Brendan McDermid/Combination/File Photo

(Reuters) – Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk’s (NOVOb.CO) Wegovy and Eli Lilly’s (LLY.N) Zepbound result in both fat and muscle loss that can increase the risk of falls and decrease overall strength, which could be especially harmful for older patients.

The following companies are developing weight-loss treatments that help preserve or grow muscles while patients shed pounds:

Advertisement

Eli Lilly

The U.S. drugmaker spent nearly $2 billion in 2023 to acquire Versanis Bio’s bimagrumab, which prevents the activity of a protein called myostatin to…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here